Literature DB >> 22783787

Acute intermittent porphyria: fatal complications of treatment.

P E Stein1, M N Badminton, J H Barth, D C Rees, R Sarkany, M F Stewart, T M Cox.   

Abstract

Acute neurovisceral attacks of porphyria can be life threatening. They are rare and notoriously difficult to diagnose clinically, but should be considered, particularly in female patients with unexplained abdominal pain, and associated neurological or psychiatric features or hyponatraemia. The diagnosis might be suggested by altered urine colour and can be confirmed by finding an elevated porphobilinogen concentration in fresh urine protected from light. Severe attacks require treatment with intravenous haem arginate and supportive management with safe drugs, including adequate analgesia. Intravenous glucose in water solutions are contraindicated as they aggravate hyponatraemia, which can prove fatal.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783787      PMCID: PMC4953498          DOI: 10.7861/clinmedicine.12-3-293

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

1.  Treatment of an acute attack of porphyria during pregnancy.

Authors:  M N Badminton; J-C Deybach
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

2.  A retrospective analysis of outcome of pregnancy in patients with acute porphyria.

Authors:  Joanne T Marsden; David C Rees
Journal:  J Inherit Metab Dis       Date:  2010-06-22       Impact factor: 4.982

Review 3.  Porphyrias.

Authors:  Hervé Puy; Laurent Gouya; Jean-Charles Deybach
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

4.  Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.

Authors:  Christoph Handschin; Jiandie Lin; James Rhee; Anne-Kathrin Peyer; Sherry Chin; Pei-Hsuan Wu; Urs A Meyer; Bruce M Spiegelman
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

5.  An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity.

Authors:  Richard J Hift; Peter N Meissner
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

6.  Early administration of heme arginate for acute porphyric attacks.

Authors:  P Mustajoki; Y Nordmann
Journal:  Arch Intern Med       Date:  1993-09-13
  6 in total
  6 in total

1.  [Altered orientation and aggressiveness in an 89-year-old woman].

Authors:  M Kowar; A H Jacobs
Journal:  Internist (Berl)       Date:  2018-01       Impact factor: 0.743

2.  Axonal Polyneuropathy in a Man Treated for Pulmonary Cocci: A Case of Acute Intermittent Porphyria.

Authors:  Kevin J Guzman; Laxmi A Suthar
Journal:  Am J Case Rep       Date:  2019-09-18

3.  EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.

Authors:  Laurent Gouya; Paolo Ventura; Manisha Balwani; D Montgomery Bissell; David C Rees; Ulrich Stölzel; John D Phillips; Raili Kauppinen; Janneke G Langendonk; Robert J Desnick; Jean-Charles Deybach; Herbert L Bonkovsky; Charles Parker; Hetanshi Naik; Michael Badminton; Penelope E Stein; Elisabeth Minder; Jerzy Windyga; Radan Bruha; Maria Domenica Cappellini; Eliane Sardh; Pauline Harper; Sverre Sandberg; Aasne K Aarsand; Janice Andersen; Félix Alegre; Aneta Ivanova; Neila Talbi; Amy Chan; William Querbes; John Ko; Craig Penz; Shangbin Liu; Tim Lin; Amy Simon; Karl E Anderson
Journal:  Hepatology       Date:  2019-11-07       Impact factor: 17.425

Review 4.  Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Authors:  Helene J Bustad; Juha P Kallio; Marta Vorland; Valeria Fiorentino; Sverre Sandberg; Caroline Schmitt; Aasne K Aarsand; Aurora Martinez
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 5.  Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.

Authors:  Matteo Marcacci; Andrea Ricci; Chiara Cuoghi; Stefano Marchini; Antonello Pietrangelo; Paolo Ventura
Journal:  Orphanet J Rare Dis       Date:  2022-04-07       Impact factor: 4.123

6.  Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.

Authors:  Bruce Wang; Paolo Ventura; Kei-Ichiro Takase; Manish Thapar; David Cassiman; Ilja Kubisch; Shangbin Liu; Marianne T Sweetser; Manisha Balwani
Journal:  Orphanet J Rare Dis       Date:  2022-08-26       Impact factor: 4.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.